Skip to main content

Table 3 Echocardiographic findings at baseline and after 6 and 12 months

From: Linking cell function with perfusion: insights from the transcatheter delivery of bone marrow-derived CD133+ cells in ischemic refractory cardiomyopathy trial (RECARDIO)

Parameter

Baseline

6 months

12 months

p value

LVEF (%)

41.1 ± 9.5

40.9 ± 11.0

39.5 ± 10.7

0.76

LVESV (ml)

93.4 ± 38.5

92.1 ± 36.6

96.3 ± 40.1

0.78

LVEDV (ml)

153.5 ± 45.0

152.1 ± 33.7

154.2 ± 36.9

0.96

WMSI

1.8 ± 0.5

1.8 ± 0.5

1.9 ± 0.5

0.43

  1. Data presented as mean ± standard deviation
  2. LVEF left ventricular ejection fraction, LVESV left ventricular end-systolic volume, LVEDV left ventricular end-diastolic volume, WMSI wall motion score index
Back to article page

Stem Cell Research & Therapy

ISSN: 1757-6512